Table 2.
Variable | Coefficient | 95% confidence interval | P value | Residual I 2 |
---|---|---|---|---|
Dosea | 0.01 | −0.02 to 0.04 | 0.46 | 67% |
Unpublished | −0.44 | −1.04 to 0.16 | 0.13 | 74% |
Poor quality | 0.44 | −0.57 to 1.45 | 0.35 | 77% |
Poor quality or unpublished study | −0.23 | −0.84 to 0.38 | 0.42 | 78% |
Non-US-based study | −0.70 | −1.02 to -0.35 | 0.001 | 24% |
Duration 8 weeks (vs 6 weeks) | 0.10 | −0.29 to 0.48 | 0.58 | 77% |
Baseline MADRS score | −0.11 | −0.33 to 0.11 | 0.29 | 75% |
Proportion of study participants non-White | −0.04 | −0.05 to -0.02 | <0.001 | 0% |
aPlacebo arm partitioned for multi-arm trial.